Brought to you by 
Series B round brings $45mm to Harpoon Therapeutics; receives $20mm second tranche
15 Mar 2019
Executive Summary
Oncology start-up Harpoon Therapeutics raised $45mm through its Series B round. Arix Bioscience and New Leaf Ventures co-led, and were joined by additional investor Taiho Ventures and returning backer MPM Capital. Arix and New Leaf have joined Harpoon’s board of directors, and Taiho’s president will be on the board as an observer.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B round brings $45mm to Harpoon Therapeutics; receives $20mm second tranche
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice